Stockreport

Global Transplant Complications Drug Development Pipeline Review 2018 Featuring Medeor Therapeutics, Amgen and Novartis

Cellect Biotechnology Ltd. - American Depositary Shares  (APOP) 
US:NASDAQ Investor Relations: cellect.co
PDF DUBLIN, Dec. 18, 2018 /PRNewswire/ -- The "Transplant Complications Drug Development Pipeline Review, 2018" report has been added to ResearchAndMarkets.com's offering.Th [Read more]